Skip to main content
Michael Khodadoust, MD, Oncology, Stanford, CA

Michael Siavash Khodadoust MD


Physician

Join to View Full Profile
  • 300 Pasteur DrStanford, CA 94305

  • Phone+1 650-723-4000

  • Fax+1 650-724-1231

Dr. Khodadoust is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2012 - 2015
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 2010

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2025
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Targeted Killing of TNFR2-Expressing Tumor Cells and Tregs by TNFR2 Antagonistic Antibodies in Advanced Sézary Syndrome  
    D L Faustman, Y H Kim, M Khodadoust, Nature
  • Pembrolizumab in Mycosis Fungoides and Sézary Syndrome: Updated Results of the CITN Multicenter Phase 2 Study  
    Michael S Khodadoust, Pierluigi Porcu, Francine Foss, Andrei R Shustov, Satish Shanbhag, Lubomir Sokol, Steven M Horwitz, Elad Sharon, European Journal of Cancer
  • IPH4102 in relapsed/refractory Cutaneous T Cell Lymphoma (CTCL): Results of the First-in-Human Multicenter Phase 1 Study  
    Pierluigi Porcu, Basem William, Michael Khodadoust, European Journal of Cancer

Abstracts/Posters

  • Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy
    Michael S. Khodadoust, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Maria-I: A Deep-Learning Approach for Accurate Prediction of MHC Class I Tumor Neoantigen Presentation
    Michael S. Khodadoust, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Follicular Lymphoma Organoids for Investigating the Tumor Microenvironment
    Michael S. Khodadoust, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Intratumoral Injection of CpG-ODN Plus Systemic Ibrutinib Induces an Anti-Tumor Immune Response Affecting T Cell Subsets in the Microenvironment of Both Injected and N... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Authored Content

  • Pembrolizumab in Mycosis Fungoides and Sézary Syndrome: Updated Results of the CITN Multicenter Phase 2 StudyAugust 2018
  • Profiling Tumor Infiltrating Immune Cells with CIBERSORTJanuary 2018

Press Mentions

  • Stanford Coach’s Quest to Save His Brother: ‘God, I Hope This Works’
    Stanford Coach’s Quest to Save His Brother: ‘God, I Hope This Works’November 12th, 2020
  • ‘Liquid Biopsy’ Predicts Lymphoma Therapy Success Within Days
    ‘Liquid Biopsy’ Predicts Lymphoma Therapy Success Within DaysAugust 20th, 2018
  • New Computational Tool Enables Powerful Molecular Analysis of Biomedical Tissue Samples
    New Computational Tool Enables Powerful Molecular Analysis of Biomedical Tissue SamplesMay 8th, 2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: